
#AI Drug Discovery
26 articles




Pharma Strategy
Novo Nordisk Licenses Cell Therapy Program to AI Firm as Stock Rallies 25%
Via News Editorial Team•






Pharma Strategy
Novo Nordisk's 24.9% Rally Validates AI Licensing Over Internal Cell Therapy
Via News Editorial Team•










